{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:05:23Z","timestamp":1791144323420,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001661","name":"Universit\u00e4t Heidelberg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.eclinm.2023.101938","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T05:02:22Z","timestamp":1680757342000},"page":"101938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Global prevalence of hepatitis B or hepatitis C infection among patients with tuberculosis disease: systematic review and meta-analysis"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3392-9257","authenticated-orcid":false,"given":"Ioana D.","family":"Olaru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Beliz Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuad","family":"Mirzayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevena","family":"Prodanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Kitchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel G.","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7216-7067","authenticated-orcid":false,"given":"Claudia M.","family":"Denkinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2023.101938_bib1","series-title":"Global tuberculosis report 2022","year":"2022"},{"key":"10.1016\/j.eclinm.2023.101938_bib2","series-title":"Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. accountability for the global health sector strategies 2016\u20132021: actions for impact","year":"2021"},{"key":"10.1016\/j.eclinm.2023.101938_bib3","series-title":"Global hepatitis report 2017","year":"2017"},{"issue":"8","key":"10.1016\/j.eclinm.2023.101938_bib4","doi-asserted-by":"crossref","first-page":"e568","DOI":"10.1016\/S2214-109X(16)30101-2","article-title":"Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in the Gambia: an economic modelling analysis","volume":"4","author":"Nayagam","year":"2016","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.eclinm.2023.101938_bib5","series-title":"Global hepatitis report 2017","article-title":"WHO estimates of the prevalence and incidence of hepatitis C virus infection by World Health Organization region, 2015","year":"2018"},{"key":"10.1016\/j.eclinm.2023.101938_bib6","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.eclinm.2023.101938_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","article-title":"Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data","volume":"13","author":"Munn","year":"2015","journal-title":"Int J Evid Based Healthc"},{"issue":"2","key":"10.1016\/j.eclinm.2023.101938_bib8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jcma.2017.10.002","article-title":"The susceptibility of anti-tuberculosis drug-induced liver injury and chronic hepatitis C infection: a systematic review and meta-analysis","volume":"81","author":"Chang","year":"2018","journal-title":"J\u00a0Chin Med Assoc"},{"issue":"6","key":"10.1016\/j.eclinm.2023.101938_bib9","doi-asserted-by":"crossref","first-page":"800","DOI":"10.5588\/ijtld.15.0668","article-title":"Frequency and risk factors of drug-induced liver injury during treatment of multidrug-resistant tuberculosis","volume":"20","author":"Lee","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"10.1016\/j.eclinm.2023.101938_bib10","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1186\/s12879-019-4494-1","article-title":"Hepatitis C virus infection: a challenge in the complex management of two cases of multidrug-resistant tuberculosis","volume":"19","author":"Musso","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.eclinm.2023.101938_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/644591a8-8ae6-450e-974e-1cd1f08f52c7","article-title":"Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa","volume":"8","author":"Shean","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.eclinm.2023.101938_bib12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2468-1253(19)30085-8","article-title":"The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study","volume":"4","author":"Trickey","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.eclinm.2023.101938_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/hiv.13163","article-title":"Improving healthcare for patients with HIV, tuberculosis and hepatitis C in eastern Europe: a review of current challenges and important next steps","volume":"23","author":"Kraef","year":"2021","journal-title":"HIV Med"},{"issue":"6","key":"10.1016\/j.eclinm.2023.101938_bib14","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.cmi.2021.03.031","article-title":"Standard versus high dose of rifampicin in the treatment of pulmonary tuberculosis: a systematic review and meta-analysis","volume":"27","author":"Onorato","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"10.1016\/j.eclinm.2023.101938_bib15","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An official ATS statement: hepatotoxicity of antituberculosis therapy","volume":"174","author":"Saukkonen","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.eclinm.2023.101938_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12879-018-3192-8","article-title":"Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment","volume":"18","author":"Chen","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.eclinm.2023.101938_bib17","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/cid\/ciz241","article-title":"Antiviral therapy for hepatitis B prevents liver injury in patients with tuberculosis and hepatitis B coinfection","volume":"70","author":"Lui","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.eclinm.2023.101938_bib18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2019.03.034","article-title":"Update of the statements on biology and clinical impact of occult hepatitis B virus infection","volume":"71","author":"Raimondo","year":"2019","journal-title":"J\u00a0Hepatol"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023001153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023001153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:18:28Z","timestamp":1762899508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537023001153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":18,"alternative-id":["S2589537023001153"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.101938","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global prevalence of hepatitis B or hepatitis C infection among patients with tuberculosis disease: systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.101938","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101938"}}